RT Book, Section
A1 Longo, Dan L.
SR Print(0)
ID 1184772519
T1 Enfortumab vedotin en el carcinoma urotelial recidivante
T2 Harrisons: Actualizaciones
YR 2019
FD 2019
PB McGraw Hill
PP New York, NY
SN 
LK accessmedicina.mhmedical.com/updatesContent.aspx?gbosid=555976
RD 2023/02/07
AB